Total Payments
$25,663
2024 Payments
$4,821
Companies
22
Transactions
1,416
Medicare Patients
5,028
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$25,093 (97.8%)
Education$420.53 (1.6%)
Consulting$150.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,093 | 1,395 | 97.8% |
| Education | $420.53 | 20 | 1.6% |
| Consulting Fee | $150.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $3,976 | 236 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $3,790 | 193 | $0 (2024) |
| ABBVIE INC. | $3,456 | 210 | $0 (2024) |
| Alkermes, Inc. | $2,636 | 109 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $2,132 | 108 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $2,104 | 120 | $0 (2024) |
| Indivior Inc. | $1,826 | 77 | $0 (2024) |
| Allergan, Inc. | $1,815 | 157 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $1,424 | 90 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $612.75 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,821 | 229 | Indivior Inc. ($961.18) |
| 2023 | $3,535 | 173 | ABBVIE INC. ($1,072) |
| 2022 | $2,612 | 131 | Lundbeck LLC ($611.06) |
| 2021 | $3,189 | 207 | AbbVie Inc. ($999.75) |
| 2020 | $2,860 | 173 | Allergan, Inc. ($793.52) |
| 2019 | $4,019 | 230 | Otsuka America Pharmaceutical, Inc. ($947.25) |
| 2018 | $2,662 | 155 | Vanda Pharmaceuticals Inc. ($713.27) |
| 2017 | $1,966 | 118 | Otsuka America Pharmaceutical, Inc. ($558.73) |
All Payment Transactions
1,416 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: OUD | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: CNS | ||||||
| 12/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: CNS | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $115.83 | General |
| Category: CNS | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: CNS | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: CNS | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 914 | 2,978 | $391,916 | $186,089 |
| 2022 | 14 | 1,107 | 2,874 | $372,327 | $190,777 |
| 2021 | 14 | 1,365 | 4,867 | $622,564 | $319,641 |
| 2020 | 11 | 1,642 | 5,642 | $757,587 | $316,002 |
Total Patients
5,028
Total Services
16,361
Medicare Billing
$1.0M
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 146 | 430 | $92,235 | $45,201 | 49.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 783 | $54,270 | $42,547 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 372 | $59,371 | $22,482 | 37.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 132 | 366 | $42,794 | $17,936 | 41.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 88 | 221 | $43,095 | $15,724 | 36.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 119 | 120 | $44,460 | $14,937 | 33.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 128 | 278 | $28,356 | $14,106 | 49.7% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2023 | 39 | 40 | $6,005 | $4,708 | 78.4% |
| 90853 | Group psychotherapy | Office | 2023 | 21 | 165 | $8,714 | $3,312 | 38.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 14 | 14 | $3,276 | $1,754 | 53.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 171 | $7,226 | $1,728 | 23.9% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 16 | 18 | $2,114 | $1,653 | 78.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 646 | $44,774 | $35,622 | 79.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 173 | 436 | $44,472 | $31,891 | 71.7% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 119 | 252 | $54,054 | $28,420 | 52.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 162 | 439 | $51,321 | $24,781 | 48.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 147 | 148 | $54,834 | $21,133 | 38.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 106 | 254 | $49,365 | $18,913 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 282 | $45,007 | $17,372 | 38.6% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2022 | 35 | 35 | $5,255 | $4,177 | 79.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 50 | 239 | $10,100 | $2,381 | 23.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 75 | 86 | $5,590 | $1,955 | 35.0% |
| 90839 | Psychotherapy for crisis, first hour | Office | 2022 | 13 | 13 | $2,782 | $1,220 | 43.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 14 | 17 | $2,243 | $1,097 | 48.9% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 11 | 11 | $1,287 | $951.27 | 73.9% |
About Dr. John Head, DO
Dr. John Head, DO is a Psychiatry healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750393690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Head, DO has received a total of $25,663 in payments from pharmaceutical and medical device companies, with $4,821 received in 2024. These payments were reported across 1,416 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($25,093).
As a Medicare-enrolled provider, Head has provided services to 5,028 Medicare beneficiaries, totaling 16,361 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Detroit, MI
- Active Since 08/12/2006
- Last Updated 09/06/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750393690
Products in Payments
- REXULTI (Drug) $5,733
- VRAYLAR (Drug) $5,263
- ARISTADA (Drug) $1,901
- AUSTEDO (Drug) $1,627
- LATUDA (Drug) $1,424
- Fanapt (Drug) $1,215
- ABILIFY MAINTENA (Drug) $963.73
- PERSERIS (Drug) $903.77
- SUBLOCADE (Drug) $845.36
- BRINTELLIX (Drug) $718.10
- INGREZZA (Drug) $554.11
- HETLIOZ (Drug) $485.45
- CAPLYTA (Drug) $450.34
- TRINTELLIX (Drug) $437.09
- Hetlioz (Drug) $375.15
- INVEGA SUSTENNA (Drug) $367.68
- LYBALVI (Drug) $328.63
- Auvelity (Drug) $310.19
- Aristada 441 mg (Drug) $233.83
- ABILIFY ASIMTUFII (Drug) $191.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Detroit
Dr. Andreas Sidiropoulos, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Matcheri Keshavan, Md, MD
Psychiatry — Payments: $41,006
Psychiatry $41,006
Dr. Arash Javanbakht, Md, MD
Psychiatry — Payments: $38,102
Psychiatry $38,102
Dr. Gerald Winder, M.d, M.D
Psychiatry — Payments: $27,502
Psychiatry $27,502
David Harris
Psychiatry — Payments: $11,779
Psychiatry $11,779
Rajendra Kanneganti, M.d, M.D
Psychiatry — Payments: $8,706
Psychiatry $8,706